Difference between revisions of "Krop I, et al. J. Clin. Oncol. (2012) cited as Ref 576 in DOI: 10.1038/s41392-020-0110-5 (Q9839)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): J. Clin. Oncol., #quickstatements; #temporary_batch_1590006349955) |
(Created claim: Page(s) (P105): 2307-2313, #quickstatements; #temporary_batch_1590074839150) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Property / Volume | |||
| + | 30 | ||
| Property / Volume: 30 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors (English) | ||
| Property / title: Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 2307-2313 | ||
| Property / Page(s): 2307-2313 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Krop I, et al. J. Clin. Oncol. (2012) cited as Ref 576 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Krop I
0 references
2012
0 references
J. Clin. Oncol.
0 references
30
0 references
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors (English)
0 references
2307-2313
0 references
